Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-27 @ 6:42 AM
Study NCT ID:
NCT04233294
Status:
RECRUITING
Last Update Posted:
2020-08-14
First Post:
2020-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-15
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-12
Last Update Post Date:
2020-08-14
Last Update Post Date Type:
ACTUAL